-
Neoantigen-based dendritic cell vaccines in lung cancer: overcoming immunosuppressive barriers for durable antitumor immunit
Author: Li, Zhang; Zhang, Feiyue; Luyu, Huang; Zhang, Wenqiang; Ismail, Mahmoud; Rueckert, Jens-C
Journal: CANCER TREATMENT REVIEWS. 2026; Vol. 145, Issue , pp. -. DOI: 10.1016/j.ctrv.2026.103125
-
Circulating tumor DNA in breast cancer: From technological foundation to clinical implementatio
Author: Lin, Xinyi; Liu, Baiying; Wu, Jing; Shi, Lina; Zhang, Yanyan; Yang, Qiaoyu; Tang, Haiyun; Xu, Shaoting; Gao, Yuxuan; Cui, Jihong; Zhang, Yunjian
Journal: CANCER TREATMENT REVIEWS. 2026; Vol. 144, Issue , pp. -. DOI: 10.1016/j.ctrv.2026.103108
-
Targeted precision Strike in Extensive-Stage small cell lung Cancer: Current advances and future Perspectives for Antibody-Drug conjugate
Author: Li, Yuwei; Chen, Kaiyan; Li, Hui; Fan, Yun
Journal: CANCER TREATMENT REVIEWS. 2026; Vol. 143, Issue , pp. -. DOI: 10.1016/j.ctrv.2026.103091
-
Intracranial activity of antibody-drug conjugates in advanced non-small cell lung cancer: What have we accomplished so far
Author: Cheo, Seng Wee; Li, Molly S. C.; Huang, Derek De-Rui; Saw, Stephanie P. L.; Hendriks, Lizza E. L.; Remon, Jordi; Menis, Jessica; Addeo, Alfredo; Voon, Pei Jye
Journal: CANCER TREATMENT REVIEWS. 2026; Vol. 143, Issue , pp. -. DOI: 10.1016/j.ctrv.2025.103083
-
Long and short-term efficacy and safety comparison of nab-paclitaxel versus paclitaxel combined with trastuzumab and pertuzumab for neoadjuvant treatment of HER2-positive breast cancer: A systematic review and meta-analysi
Author: Yuan, Ye; Long, Xin; Wei, Mengya; Chen, Li; Zhang, Ji; Liu, Xumei
Journal: CANCER TREATMENT REVIEWS. 2025; Vol. 138, Issue , pp. -. DOI: 10.1016/j.ctrv.2025.102975
-
Chimeric antigen receptor NK cells for breast cancer immunotherap
Author: Wu, Nisha; Yang, Ning; Zhang, Shiqi; Wu, Haoran; Fang, Xuechun; Lin, Wanying; Zhang, Yi; Qi, Xiaowei; Gong, Ying
Journal: CANCER TREATMENT REVIEWS. 2025; Vol. 137, Issue , pp. -. DOI: 10.1016/j.ctrv.2025.102943
-
Management approaches for recurrent or metastatic head and neck squamous cell carcinoma after anti-PD-1/PD-L1 immunotherap
Author: Tahara, Makoto; Lim, Darren Wan-Teck; Keam, Bhumsuk; Ma, Brigette; Zhang, Li; Wang, Chaojun; Guo, Ye
Journal: CANCER TREATMENT REVIEWS. 2025; Vol. 136, Issue , pp. -. DOI: 10.1016/j.ctrv.2025.102938
-
Operationalizing intermediate clinical endpoints: A pragmatic framework for prostate cancer management trial
Author: Xiong, Xingyu; Zhang, Shiyu; Du, Jiajia; Liao, Xinyang; Yang, Jie; Zheng, Weitao; Xu, Hang; Yang, Lu; Wei, Qiang
Journal: CANCER TREATMENT REVIEWS. 2025; Vol. 136, Issue , pp. -. DOI: 10.1016/j.ctrv.2025.102935
